PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1398892-0	1992	Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.	Desoxycorticosterone Acetate	39-66	arginine vasopressin	Rattus norvegicus	14-25	
1398892-1	1992	Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension.	Desoxycorticosterone Acetate	105-132	arginine vasopressin receptor 2	Rattus norvegicus	148-178	
1398892-1	1992	Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension.	Desoxycorticosterone Acetate	105-132	arginine vasopressin	Rattus norvegicus	148-159	
1398892-1	1992	Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension.	Desoxycorticosterone Acetate	134-138	arginine vasopressin receptor 2	Rattus norvegicus	148-178	
1398892-1	1992	Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension.	Desoxycorticosterone Acetate	134-138	arginine vasopressin	Rattus norvegicus	148-159